Home > Formulary : Adult > Chapters > 4. Central Nervous System >
BNSSG Adult Joint Formulary
4.4 Nausea and labyrinth disorders
Last edited: 24-10-2024
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Antihistamines
Also refer to Chapter 16 - Palliative Care
Recommended: (TLS Green)
Prochlorperazine
Cyclizine
Pyridoxine hydrochloride / doxylamine succinate (Xonvea) tablets (TLS Amber Specialist Initiated)
-
For the treatment of nausea and vomiting of pregnancy in pregnant women aged 18 years or over who do not respond to conservative management
-
For use when a trial of first and second line antiemetics has not controlled symptoms
Antimuscarinics
Hyoscine hydrobromide patch
- For treatment of nausea and vomiting associated with vestibular disorder and to reduce secretions in neurological conditions
Antipsychotics (first-generation)
Levomepromazine (TLS Blue)
- On advice of palliative care
Haloperidol (TLS Blue)
- On advice of palliative care
Droperidol (TLS Red)
- For treatment and prophylaxis of PONV, and prevention of nausea and vomiting caused by opioid analgesia in PCA
- Droperidol is contraindicated in patients taking drugs that prolong the QT interval (avoid concomitant administration of drugs that prolong QT interval), hypokalaemia, hypomagnesaemia and bradycardia
Dopamine receptor antagonists
MHRA Metoclopramide: risk of neurological adverse effects
MHRA Domperidone: risks of cardiac side effects
Domperidone (TLS Green)
Domperidone (off label) (TLS Blue)
- after assessment and guidance from a trained professional skilled in breastfeeding support / after non-pharmacological measures have been tried to stimulate lactation.
- To increase breastmilk supply (short course 10mg TDS for 7 days then a suggested reducing regimen such as 10mg BD for 7 days, then 10mg OD for 7 days, then stop.
- See SPS guidance on Using domperidone for low milk supply
Metoclopramide
5HT3 Receptor Antagonists
Recommended: (TLS Green)
Ondansetron
- For cytotoxic chemotherapy and radiotherapy induced vomiting
- Alternative 2nd line (Blue) for Post-operative Nausea and Vomiting
Alternative: (TLS Red)
Granisetron
Specific indication: (TLS Red)
Palonosetron
- NBT ONLY - for patients with Hodgkin's lymphoma being treated with ABVD protocol
Neurokinin receptor antagonists
Aprepitant (TLS Red)
- For use in Cytotoxic chemotherapy according to guidelines
Aprepitant (TLS Red)
- For prevention of post-operative nausea and vomiting for patients attending for adult anti-reflux surgery
Fosaprepitant (TLS Red)
- UHB only
- For use in Cytotoxic chemotherapy according to guidelines
Netupitant 300mg / Palonosetron 0.5mg (Akynzeo®) (TLS Red)
- For haematology and oncology patients receiving highly emetogenic chemotherapy or those who have experienced breakthrough nausea and vomiting on a moderately emetogenic chemotherapy protocol despite optimal antiemetic therapy
Others
Dexamethasone
- Cytotoxic chemotherapy (TLS Green)
- For PONV (TLS Blue)
Lorazepam (TLS Green)
- Pre-emptive chemotherapy induced nausea and vomiting
4.4.1 Meniere's disease
Recommended: (TLS Green)
Betahistine
Cinnarizine
Prochlorperazine
Hyoscine hydrobromide patch
- For treatment of nausea and vomiting associated with vestibular disorder and to reduce secretions in neurological conditions
Contact Us
Got a question or comment about the Joint Formulary?
Please use the email address below to contact us and we will endeavour to respond within 2 working days.